Management tracks

Tauopathy therapeutic developer Asceneuron S.A. (Lausanne, Switzerland) appointed Hans Schikan chairman. Schikan is chairman of Complix N.V. (Diepenbeek, Belgium) and InteRNA Technologies B.V. (Nijmegen, the Netherlands) and previously was CEO of Prosensa Holding N.V., which BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) acquired.

Biosimilar play Epirus Biopharmaceuticals Inc. (NASDAQ:EPRS) hired Vincent Aurentz as CBO. Aurentz was president of HemoShear LLC (Charlottesville, Va.). ...